IBDEI1IR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25389,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,25389,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,25390,0)
 ;;=C78.7^^124^1246^84
 ;;^UTILITY(U,$J,358.3,25390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25390,1,3,0)
 ;;=3^Secondary Malig Neop of Liver/Intrahepatic Bile Duct
 ;;^UTILITY(U,$J,358.3,25390,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,25390,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,25391,0)
 ;;=C79.31^^124^1246^82
 ;;^UTILITY(U,$J,358.3,25391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25391,1,3,0)
 ;;=3^Secondary Malig Neop of Brain
 ;;^UTILITY(U,$J,358.3,25391,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,25391,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,25392,0)
 ;;=C79.49^^124^1246^87
 ;;^UTILITY(U,$J,358.3,25392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25392,1,3,0)
 ;;=3^Secondary Malig Neop of Nervous System
 ;;^UTILITY(U,$J,358.3,25392,1,4,0)
 ;;=4^C79.49
 ;;^UTILITY(U,$J,358.3,25392,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,25393,0)
 ;;=C79.32^^124^1246^83
 ;;^UTILITY(U,$J,358.3,25393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25393,1,3,0)
 ;;=3^Secondary Malig Neop of Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,25393,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,25393,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,25394,0)
 ;;=C79.51^^124^1246^80
 ;;^UTILITY(U,$J,358.3,25394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25394,1,3,0)
 ;;=3^Secondary Malig Neop of Bone
 ;;^UTILITY(U,$J,358.3,25394,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,25394,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,25395,0)
 ;;=C79.52^^124^1246^81
 ;;^UTILITY(U,$J,358.3,25395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25395,1,3,0)
 ;;=3^Secondary Malig Neop of Bone Marrow
 ;;^UTILITY(U,$J,358.3,25395,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,25395,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,25396,0)
 ;;=C79.70^^124^1246^79
 ;;^UTILITY(U,$J,358.3,25396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25396,1,3,0)
 ;;=3^Secondary Malig Neop of Adrenal Gland,Unspec
 ;;^UTILITY(U,$J,358.3,25396,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,25396,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,25397,0)
 ;;=C83.30^^124^1246^11
 ;;^UTILITY(U,$J,358.3,25397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25397,1,3,0)
 ;;=3^Diffuse Large B-Cell Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,25397,1,4,0)
 ;;=4^C83.30
 ;;^UTILITY(U,$J,358.3,25397,2)
 ;;=^5001571
 ;;^UTILITY(U,$J,358.3,25398,0)
 ;;=C83.39^^124^1246^10
 ;;^UTILITY(U,$J,358.3,25398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25398,1,3,0)
 ;;=3^Diffuse Large B-Cell Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,25398,1,4,0)
 ;;=4^C83.39
 ;;^UTILITY(U,$J,358.3,25398,2)
 ;;=^5001580
 ;;^UTILITY(U,$J,358.3,25399,0)
 ;;=C83.50^^124^1246^23
 ;;^UTILITY(U,$J,358.3,25399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25399,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,25399,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,25399,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,25400,0)
 ;;=C83.59^^124^1246^22
 ;;^UTILITY(U,$J,358.3,25400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25400,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,25400,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,25400,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,25401,0)
 ;;=C81.90^^124^1246^14
 ;;^UTILITY(U,$J,358.3,25401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25401,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site,Unspec
 ;;^UTILITY(U,$J,358.3,25401,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,25401,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,25402,0)
 ;;=C81.99^^124^1246^13
